Trademark: 87226817
Word
COUMADIN (WARFARIN SODIUM TABLETS, USP)
Status
Dead
Status Code
710
Status Date
Friday, December 29, 2023
Serial Number
87226817
Registration Number
5222641
Registration Date
Tuesday, June 13, 2017
Mark Type
3000
Filing Date
Friday, November 4, 2016
Published for Opposition
Tuesday, March 28, 2017
Cancellation Date
Friday, December 29, 2023
Trademark Owner History
Bristol-Myers Squibb Pharma Company - Original Registrant
Classifications
5 An anticoagulant pharmaceutical preparation
The mark consists of the words "COUMADIN (WARFARIN SODIUM TABLETS, USP)" in black font and a design of a splash in the colors purple, pink, blue, beige, white and black on a yellow background.
The color(s) purple, pink, blue, beige, white, yellow and black is/are claimed as a feature of the mark.
"(WARFARIN SODIUM TABLETS, USP)"
Trademark Events
Dec 29, 2023
Cancelled Sec. 8 (6-Yr)
Jun 13, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 13, 2017
Registered-Principal Register
Mar 28, 2017
Official Gazette Publication Confirmation E-Mailed
Mar 28, 2017
Published For Opposition
Mar 8, 2017
Notification Of Notice Of Publication E-Mailed
Feb 16, 2017
Approved For Pub - Principal Register
Feb 12, 2017
Assigned To Examiner
Nov 9, 2016
Notice Of Design Search Code E-Mailed
Nov 8, 2016
New Application Office Supplied Data Entered
Nov 8, 2016
New Application Entered
AREA
S
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov